Case seriesIncreasing evidence for omalizumab in the treatment of bullous pemphigoid
Under a Creative Commons license
open access
Key words
autoimmune skin disease
bullous pemphigoid
IgE
omalizumab
steroid sparing
Abbreviations used
BP
Bullous pemphigoid
DIF
Direct immunofluorescence
Cited by (0)
Funding sources: None.
Conflicts of interest: None disclosed.
© 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.